Porth's Essentials of Pathophysiology, 4e

953

Disorders of Brain Function

C h a p t e r 3 7

4. Fuller GN, Goodman JC, Bouldin TW, et al. The nervous system. In: Rubin R, Strayer DE, eds. Rubin’s Pathology: Clinicopathologic Foundations of Medicine . 5th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012:1295–1392. 5. Arundine M, Tymianski M. Molecular mechanisms of glutamate- dependent neurogeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 2004;61:657–668. 6. Kalia LW, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 2008;7: 742–755. 7. Hickey JV. The Clinical Practice of Neurological and Neurosurgical Nursing . 6th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2009:117–120, 270–307, 370–409, 496–520, 588–619, 646–664. 8. Noble KA. Traumatic brain injury and increased intracranial pressure. J Perianesth Nurs. 2010;25(4):242–250. 9. Ropper AH. Coma. In: Hauser SL, ed. Harrison’s Neurology in Clinical Medicine . New York, NY: McGraw-Hill; 2010:130–139. 10. Biennow K. The neuropathology and neurobiology of traumatic brain injury. Neuron. 2012;76(Dec 6):886–899. 11. Almasi SJ, Wilson JJ. An update on the diagnosis and management of concussion. WMJ. 2012;111(1):21–27. 12. Ropper AH, Gorson KC. Concussion. N Engl J Med. 2007;356(2): 166–172. 13. Goldfine AM, Schiff ND. Consciousness: its neurobiology and the major classes of impairment. Neurol Clin. 2011;29(4): 723–737. 14. Posner JB, Stupor CB, Schiff ND, et al. Plum and Posner’s Diagnosis of Stupor and Coma . New York, NY: Oxford University Press; 2007. 15. Ingersoll GL, Leyden DB. The glasgow coma scale for patients with head injuries. Crit Care Nurs. 1987;7(5):26–32. 16. Teasdale GM. Revisiting the glasgow coma scale and coma score. Intensive Care Med. 2000;26:153–154. 17. Moore KL, Dalley AF, Agur AMP. Clinically Oriented Anatomy . 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:882–886. 18. Smith WS, English JD, Johnston SC. Cerebrovascular disease. In Hauser SL, ed. Harrison’s Neurology in Clinical Medicine . New York, NY: McGraw-Hill; 2010:246–281. 19. American Stroke Association. Heart disease and stroke statistics—2012 update. Circulation. 2012;125:e2–e225. 20. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–2089. 21. Goldstein LB, Bushnell CD, Adams RJ. Guidelines for primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517–584. 22. Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med. 2007;83:389–394. 23. Paciaroni M, Caso V, Agnelli G. The concept of ischemic penumbra in acute stroke and therapeutic opportunities. Eur Neurol. 2009;61:321–330. 24. Siket MS, Edlow JA. Transient ischemic attack. Emerg Med Clin North Am. 2012;30(3):745–770. 25. Manglia A, Navi BB, Layton K. Transient global ishemia and risk of stroke. Stroke. 2013;44:2064–2089. 26. Easton JD, Chair. Definition and evaluation of transient ischemic attack: a scientific statement from the American Heart Association/American Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40:2276–2293.

27. Aguilar MI, Freeman VVD. Spontaneous intracerebral hemorrhage. Semin Neurol. 2010;30(5):555–564. 28. Morgenstern LB, Hemphill Claude H III, Anderson C, et al. Guidelines for management of spontaneous intracerebral hemorrhage in adults: A guideline for Healthcare Professionals from the American Heart Association/American Stroke Association/American Stroke Association. Stroke. 2010;41:2108–2129. 29. Mayer SA, Brun NC, Bergtrup MS, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352(8):777–785. 30. Leissinger CA, Blatt PM, Hoots K, et al. Role of prothrombin complex concentrates in reversing anticoagulation: a review of the literature. Am J Hematol. 2008;83(2):137–143. 31. Jauch EC, Saver JL, Adams HP, et al. Guidelines for early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947. 32. Caulfield AF, Wijman CAC. Management of acute ischemic stroke. Neurol Clin. 2008;26:345–371. 33. van der Worp HB, van Gijn J. Acute ischemic stroke. N Engl J Med. 2007;357(6):572–579. 34. Gorelick AR, Gorelick P, Sloan EP. Emergency department evaluation and management of stroke: acute assessment, stroke teams and care pathways. Neurol Clin. 2008;26:923–942. 35. Lansberg MG, O’Connell MJ, Khartri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2012;141 (2 Suppl):e601S–e636S. 36. del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for acute ischemic stroke: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945–2948. 37. Demchuk AM, Gupta AM, Pooja RK. Emerging therapies. Continuum. 2008;14(6):80–97. 38. Duncan PW, Zorowitz R, Bates B, et al. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke. 2005;36:e100–e143. 39. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387–396. 40. Connelly ES, Rabinstein AA, Carbuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–1737. 41. Friedlander RM. Arteriovenous malformations of the brain. N Engl J Med. 2007;356:2704–2712. 42. Ogilvy CS. Chair, Special Writing Group of the Stroke Council, American Heart Association. Recommendations for management of intracranial arteriovenous malformations. Stroke. 2001;32:1458–1471. 43. Roos KL, Tyler KL. Meningitis, encephalitis, brain abscesses, and empyema. In Hauser SL, ed. Harrison’s Neurology in Clinical Medicine . 2nd ed. New York, NY: McGraw-Hill; 2010:451–483. 44. Bamberger DM. Diagnosis, initial management, and prevention of meningitis. Am Fam Physician. 2010;82(2):1491–1498. 45. Honda H, Warren DK. Central nervous system infections: meningitis and brain abscesses. Infect Dis Clin North Am. 2009;23:609–623. 46. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (AICP). MMWR. 2013;62(2):1–30. 47. Kelly D. An encephalitis primer. Adv Exp Med Biol. 2013;764:133–140. 48. Huffner A. Overview of primary brain tumors. Hematol Oncol Clin North Am. 2012;26:715–732.